What this market covers
Knee replacement implants fixed by bone growth into a porous surface instead of bone cement. Used in orthopaedic surgery, often for younger and active patients.
Typical segments
- Porous coated tibial implants
- Femoral components
- Patellar components
- Robotic assisted systems
Source: Eurostat
Why this market is moving now
- Extra-EU import value moved +58% from 2020 to 2025, a direct read on EU demand for sourced supply.
- Supply is concentrated: one country provided a large share of extra-EU imports in 2025.
- US employment in the core industry shifted +3% since 2020.
Key figures
Each figure names the source it came from. Open the source list below to read the quoted line.
| Figure | Value | Year | Source |
|---|---|---|---|
| The EU imported €2.39 billion of products under CN code 90213100 (Artificial joints for orthopaedic purposes) from outside the EU in 2025. | 2.39 EUR billion | 2025 | Eurostat |
| Extra-EU imports of CN 90213100 were up 58% in 2025 compared with 2020 (€1.51 billion), calculated from Eurostat values. | +58 % change | 2025 | Eurostat |
| EU exports of CN 90213100 to countries outside the EU were worth €5.77 billion in 2025. | 5.77 EUR billion | 2025 | Eurostat |
| Trade between EU member states in CN 90213100 (intra-EU arrivals) came to €3.96 billion in 2025. | 3.96 EUR billion | 2025 | Eurostat |
| Switzerland was the largest non-EU supplier of CN 90213100 to the EU in 2025, with €1.03 billion, or 43% of extra-EU imports. | 1.03 EUR billion | 2025 | Eurostat |
| EU exports of CN 90213100 to the United States were €2.44 billion in 2025. | 2.44 EUR billion | 2025 | Eurostat |
| The average value of extra-EU imports of CN 90213100 was €594.99 per kilogram in 2025, calculated from Eurostat value and weight. | 594.99 EUR per kg | 2025 | Eurostat |
| Netherlands was the largest EU exporter of CN 90213100 to non-EU countries in 2025, at €1.96 billion. | 1.96 EUR billion | 2025 | Eurostat |
| The EU had 63,227 enterprises in NACE class C3250 (Manufacture of medical and dental instruments and supplies) in 2023. | 63,227 enterprises | 2023 | Eurostat |
| EU enterprises in NACE class C3250 had net turnover of €105.31 billion in 2021. | 105.31 EUR billion | 2021 | Eurostat |
| NACE class C3250 employed 600,000 people across the EU in 2023. | 600,000 persons employed | 2023 | Eurostat |
| The US had 3,528 private establishments in NAICS 339113 (Surgical appliance and supplies manufacturing) in 2025. | 3,528 establishments | 2025 | U.S. Bureau of Labor Statistics |
| NAICS 339113 employed an average of 105,116 people in US private industry in 2025. | 105,116 jobs | 2025 | U.S. Bureau of Labor Statistics |
| US employment in NAICS 339113 changed by +3% between 2020 (102,053 jobs) and 2025, calculated from BLS figures. | +3 % change | 2025 | U.S. Bureau of Labor Statistics |
| Average annual pay in US NAICS 339113 was $102,311 in 2025. | 102,311 USD per year | 2025 | U.S. Bureau of Labor Statistics |
| The FDA has recorded 32 510(k) clearances for devices named "knee prosthesis". | 32 510(k) clearances | 2026 | U.S. Food and Drug Administration |
| 2 of those clearances were issued from 2021 to 2025. | 2 510(k) clearances | 2025 | U.S. Food and Drug Administration |
| Biomet, Inc. holds 5 510(k) clearances for devices named "knee prosthesis". | 5 510(k) clearances | 2026 | U.S. Food and Drug Administration |
| Depuy Orthopaedics, Inc. holds 5 510(k) clearances for devices named "knee prosthesis". | 5 510(k) clearances | 2026 | U.S. Food and Drug Administration |
| Osteonics Corp. holds 4 510(k) clearances for devices named "knee prosthesis". | 4 510(k) clearances | 2026 | U.S. Food and Drug Administration |
| Johnson & Johnson Professionals, Inc. holds 3 510(k) clearances for devices named "knee prosthesis". | 3 510(k) clearances | 2026 | U.S. Food and Drug Administration |
| Dow Corning Wright holds 2 510(k) clearances for devices named "knee prosthesis". | 2 510(k) clearances | 2026 | U.S. Food and Drug Administration |
| Joint Medical Products Corp. holds 2 510(k) clearances for devices named "knee prosthesis". | 2 510(k) clearances | 2026 | U.S. Food and Drug Administration |
| PubMed indexed 48 papers mentioning "cementless total knee arthroplasty" in the title or abstract in 2025. | 48 papers | 2025 | U.S. National Library of Medicine |
Sources and method
The figures on this page come from the public sources listed below. Read how we work.
- Eurostat: EU trade since 1988 by HS2-4-6 and CN8 (DS-045409) (2026-11-04)
Quoted lines
- Figure 1
DS-045409, reporter EU27_2020, product 90213100, partner EXT_EU27_2020, flow import, 2025, VALUE_IN_EUROS 2392723163
- Figure 2
DS-045409, reporter EU27_2020, product 90213100, flow import, 2020 VALUE_IN_EUROS 1514515966; 2025 VALUE_IN_EUROS 2392723163
- Figure 3
DS-045409, reporter EU27_2020, product 90213100, partner EXT_EU27_2020, flow export, 2025, VALUE_IN_EUROS 5767942910
- Figure 4
DS-045409, reporter EU27_2020, product 90213100, partner INT_EU27_2020, flow import, 2025, VALUE_IN_EUROS 3962444740
- Figure 5
DS-045409, reporter EU27_2020, product 90213100, partner CH, flow import, 2025, VALUE_IN_EUROS 1034332915
- Figure 6
DS-045409, reporter EU27_2020, product 90213100, partner US, flow export, 2025, VALUE_IN_EUROS 2439391870
- Figure 7
DS-045409, reporter EU27_2020, product 90213100, flow import, 2025, VALUE_IN_EUROS 2392723163, QUANTITY_IN_100KG 40215
- Figure 1
- Eurostat: EU trade since 1988 by HS2-4-6 and CN8 (DS-045409) (2026-11-04)
Quoted lines
- Figure 8
DS-045409, reporter NL, product 90213100, partner EXT_EU27_2020, flow export, 2025, VALUE_IN_EUROS 1964651743
- Figure 8
- Eurostat: Enterprises by detailed NACE Rev. 2 activity and special aggregates (sbs_ovw_act) (2026-11-04)
Quoted lines
- Figure 9
sbs_ovw_act, geo EU27_2020, nace_r2 C3250, indic_sbs ENT_NR, 2023, 63227
- Figure 10
sbs_ovw_act, geo EU27_2020, nace_r2 C3250, indic_sbs NETTUR_MEUR, 2021, 105308
- Figure 11
sbs_ovw_act, geo EU27_2020, nace_r2 C3250, indic_sbs EMP_NR, 2023, 600000
- Figure 9
- U.S. Bureau of Labor Statistics: QCEW annual averages, NAICS 339113, 2025 (2026-11-04)
Quoted lines
- Figure 12
QCEW 2025 annual, US000, private, NAICS 339113, annual_avg_estabs 3528
- Figure 13
QCEW 2025 annual, US000, private, NAICS 339113, annual_avg_emplvl 105116
- Figure 14
QCEW 2020 annual_avg_emplvl 102053; 2025 annual_avg_emplvl 105116
- Figure 15
QCEW 2025 annual, US000, private, NAICS 339113, avg_annual_pay 102311
- Figure 12
- U.S. Food and Drug Administration: openFDA 510(k) clearances, device_name "knee prosthesis" (2026-11-04)
Quoted lines
- Figure 16
openFDA device/510k device_name:"knee prosthesis", sum of counts by decision_date = 32
- Figure 17
openFDA device/510k decision_date 2021-2025 count = 2
- Figure 16
- U.S. Food and Drug Administration: openFDA 510(k) clearances by applicant, device_name "knee prosthesis" (2026-11-04)
Quoted lines
- Figure 18
applicant.exact "Biomet, Inc." count 5
- Figure 19
applicant.exact "DePuy Orthopaedics, Inc." count 5
- Figure 20
applicant.exact "Osteonics Corp." count 4
- Figure 21
applicant.exact "Johnson & Johnson Professionals, Inc." count 3
- Figure 22
applicant.exact "Dow Corning Wright" count 2
- Figure 23
applicant.exact "Joint Medical Products Corp." count 2
- Figure 18
- U.S. National Library of Medicine: PubMed search "cementless total knee arthroplasty"[tiab] AND 2025[dp] (2026-11-04)
Quoted lines
- Figure 24
esearch count 48
- Figure 24
Buyers and suppliers
Who buys
- Hospitals
- Orthopaedic surgeons
- Ambulatory surgery centres
Large non-EU suppliers to the EU
Companies to watch
Biomet, Inc.
5 FDA 510(k) clearances for devices named "knee prosthesis".
Depuy Orthopaedics, Inc.
5 FDA 510(k) clearances for devices named "knee prosthesis".
Osteonics Corp.
4 FDA 510(k) clearances for devices named "knee prosthesis".
Johnson & Johnson Professionals, Inc.
3 FDA 510(k) clearances for devices named "knee prosthesis".
Dow Corning Wright
2 FDA 510(k) clearances for devices named "knee prosthesis".
Joint Medical Products Corp.
2 FDA 510(k) clearances for devices named "knee prosthesis".
What the full report covers
- 01Executive summary
The answer in one page: size, direction and what moves it - 02Market definition and scope
What is in and out of the European Union market - 03Market size, 2021 to 2025
Historical series and growth rates - 04Outlook to 2031
Base, low and high scenarios with stated assumptions - 05Rules, policy and deadlines
Regulation and programmes that change demand - 06Drivers and barriers
What accelerates or slows adoption, by customer segment - 07Prices, costs and margins
Unit economics where public data allows - 08Competitive landscape
8 to 12 company profiles with recent moves - 09Opportunities and risks
For new entrants, suppliers and investors - 10Method and sources
Every assumption and source, listed
Included with the full report
- PDF report, 40 to 60 pages
- Excel data pack
- Ready-to-use charts
- Method note and assumptions
- Written to order in 5 working days
Frequently asked questions
How big is the EU cementless total knee arthroplasty market?
There is no single official market total. Eurostat trade data shows the EU imported €2.39 billion of goods under CN 90213100 from outside the EU in 2025 and exported €5.77 billion.
Where does the EU import cementless total knee arthroplasty from?
Switzerland was the largest non-EU supplier in 2025. Other large suppliers included United States, United Kingdom, China.
What is the average import price of cementless total knee arthroplasty in the EU?
Dividing Eurostat import value by weight gives about €594.99 per kilogram for CN 90213100 in 2025.
Which EU countries export the most cementless total knee arthroplasty?
Netherlands led EU exports to non-EU countries in 2025, followed by Ireland, Germany.
How many cementless total knee arthroplasty devices are cleared by the FDA?
openFDA lists 32 510(k) clearances for devices named knee prosthesis.
Which companies hold the most FDA clearances for cementless total knee arthroplasty?
By 510(k) count: Biomet, Inc., Depuy Orthopaedics, Inc., Osteonics Corp., Johnson & Johnson Professionals, Inc..
Free sample
Get a free sample of this report
We send the table of contents, two sample chapters and the method note, usually within one working day. You owe us nothing for asking.
- Full table of contents
- Two sample chapters
- Method note and data outline